About
Illudent is developing a novel small molecule precision medicine targeting solid tumors to treat cancer.
Explore Illudent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Illudent is developing a novel small molecule precision medicine targeting solid tumors to treat cancer.
Funding rounds, investor list, and risk signals — unlock with a subscription.